Structure-Activity Relationship Analysis on Antioxidant and Anticancer Actions of Theaflavins on Human Colon Cancer

Qingyun Tan, Lijiao Peng1, Yanyu Huang

  • 1Affiliated Hospital of Guangdong Medical University , Zhanjiang , Guangdong 524000 , People's Republic of China.

Insights

Theaflavins from black tea inhibit colon cancer cell growth by inducing cell cycle arrest and reducing reactive oxygen species. These natural compounds show promise as anticancer agents with a high safety index.

Area of Science:

  • Natural Product Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Natural products are increasingly recognized for their potential in cancer prevention and therapy.
  • Further research is needed to fully understand the mechanisms of action and structure-activity relationships of these compounds.

Purpose of the Study:

  • To investigate the anticancer effects of theaflavins (TFs) from black tea on human colon cancer cells.
  • To elucidate the mechanisms underlying theaflavin's cytotoxic and antioxidant activities.
  • To analyze the structure-activity relationship of TFs in relation to their biological effects.

Main Methods:

  • Cell proliferation assays using SW480 and SW620 human colon cancer cell lines.
  • Cell cycle arrest analysis.
  • Measurement of reactive oxygen species (ROS) levels.
  • Radical-scavenging activity assays (e.g., ABTS assay).
  • Structure-activity relationship analysis focusing on the galloyl group.

Main Results:

  • Theaflavins exhibited significant inhibitory effects on colon cancer cell proliferation (IC50 < 32.0 μM) via cell cycle arrest.
  • TFs demonstrated lower toxicity to normal cells, yielding a high safety index (1.89-6.26).
  • TFs effectively scavenged free radicals, reducing ROS levels in SW480 cells (e.g., TF4 IC50 for ABTS•+ was 1.91 ± 0.21 μM).
  • The galloyl group was identified as a crucial structural component influencing theaflavin's activities.

Conclusions:

  • Theaflavins possess potent antioxidant and anticancer properties against colon cancer cells.
  • TFs can serve as natural antioxidants and promising therapeutic agents for cancer treatment.
  • The findings provide valuable insights for the development of natural product-based cancer therapies.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Local Anesthetics: Chemistry and Structure-Activity Relationship01:30

Local Anesthetics: Chemistry and Structure-Activity Relationship

Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
6.7K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.8K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
978
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.2K